COMMUNIQUÉS West-GlobeNewswire
-
Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases
15/04/2026 -
HealPort Raises 1.2M USD to Scale Global Digital Health Infrastructure
15/04/2026 -
Ardena Opens New Bioanalytical Laboratory in Somerset, New Jersey
15/04/2026 -
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
15/04/2026 -
The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future
15/04/2026 -
Annual General Meeting of Kuros Biosciences approves all resolutions
15/04/2026 -
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
15/04/2026 -
What if you could reboot sick cells?
15/04/2026 -
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
15/04/2026 -
Scientific Review Raises Questions About Root Canal Safety and Whole-Body Health
15/04/2026 -
BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
15/04/2026 -
Inteleos Foundation Announces 2026 MedMissions Award to Advance Maternal Health Ultrasound Access in Five Nations
15/04/2026 -
Alira Health and Autoimmune Neurology Alliance (AiNA) Launch AXIS Registry, Advancing Real-World and Patient-Centered Research in Autoimmune Neurology
15/04/2026 -
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
15/04/2026 -
Walking Yoga App: How Combining Walking and Yoga Accelerates Weight Loss
15/04/2026 -
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
15/04/2026 -
Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
15/04/2026 -
Xenon to Present at Upcoming Investor Conferences
15/04/2026 -
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
15/04/2026
Pages